about
Acute stress facilitates trace eyeblink conditioning in C57BL/6 male mice and increases the excitability of their CA1 pyramidal neuronsSeparation of chiral 4-substituted imidazole derivatives by cyclodextrin-modified capillary electrophoresis.The rat H3 receptor: gene organization and multiple isoforms.Application of genomics to drug design: the example of the histamine H3 receptor.Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.Polymorphisms and genetic linkage of histamine receptors.Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential.Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands.Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.Are identities oral? Understanding ethnobotanical knowledge after Irish independence (1937-1939).Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity.Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics.Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-Investigation of critical parameters governing their formation and characteristics.New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors.Galloylquinic acid derivatives from Copaifera langsdorffii leaves display gastroprotective activity.Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.Optimisation of the self-assembly process: production of stable, alginate-based polyelectrolyte nanocomplexes with protamineDesign and Implementation of an Integrated Competency-Focused Pharmacy Programme: A Case Report
P50
Q30501680-6CFB8796-9CB7-48EC-9766-047B0BE49150Q30979541-19E68097-A332-479B-B96E-0D4659DBD36FQ31854892-F52BB3F8-2830-41B0-BFDE-6CC7962A09EAQ34435122-A215B547-9036-428C-BBD1-53FD75C9AE2AQ35321802-30476496-0237-443C-AD97-A6696B8DE859Q38135166-5C3DE363-CC94-4811-8EE2-D833769A1C11Q42452235-BFF6B07E-02AD-4C6F-887B-92439A950134Q43553879-A5434D47-6AE9-45A1-A780-5D3B0016F853Q44110811-391EC189-45C8-42B8-8A45-D99D3170A9B2Q45743504-1182B003-ECBD-4797-B605-9CB06FF62626Q46463546-7EDC5181-907F-4EB5-961C-DEEAB92A5509Q47783055-4646013F-8910-4980-BB64-182D2D50B9F4Q48272352-A1EA3A2A-A517-4CC6-93B8-AB6E898E96F1Q50047299-CC0DD11C-26C9-4777-B948-70FD77A5E893Q52969995-841E3238-A4F9-4769-AEFF-A1EA6DC62A8AQ52971126-09FCFE0F-FCDE-4A0E-B62E-83193AAECC76Q53658632-D82806E7-979B-4122-A311-E3C5AB13105FQ55180784-5228B7F1-D664-43B6-873C-4939FDE860E2Q60263651-05ED79A4-AB51-4003-AC1E-0C9F62259CD3Q92959762-3B270147-3B0C-4E72-9655-6C68B85BB4F5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Astrid Sasse
@ast
Astrid Sasse
@en
Astrid Sasse
@es
Astrid Sasse
@nl
type
label
Astrid Sasse
@ast
Astrid Sasse
@en
Astrid Sasse
@es
Astrid Sasse
@nl
prefLabel
Astrid Sasse
@ast
Astrid Sasse
@en
Astrid Sasse
@es
Astrid Sasse
@nl
P106
P1153
35803851000
56497235600
P21
P31
P496
0000-0001-8214-8946